1. Omeprazole just as safe in the long term

   Incidence study 17 January 2013 Pages: 2 - 2

2. Tolerability of cefaclor AF similar to standard cefaclor

   Incidence study 17 January 2013 Pages: 2 - 2

3. A higher profile for bromocriptine-associated fibrosis

   Comment 17 January 2013 Pages: 3 - 3

4. Current use of oral contraceptives (OCs) did not increase the risk of NIDDM

   Incidence study 17 January 2013 Pages: 3 - 3

5. Intraventricular teicoplanin causes convulsions in rats

   Animal 17 January 2013 Pages: 3 - 3

6. Local pain after SC epoetin

   Clinical study 17 January 2013 Pages: 3 - 3

7. Transdermal patch in a sticky situation.

   Case report 17 January 2013 Pages: 3 - 3

8. Increasing awareness of NSAID hepatotoxicity

   Comment 17 January 2013 Pages: 4 - 4

9. Reused dialysers may cause anaphylactoid reactions

   Clinical study 17 January 2013 Pages: 4 - 4

10. Valproate hepatotoxicity may be a misdiagnosis

    Case reports 17 January 2013 Pages: 4 - 4

11. 239 reports of `glossitis' and 41 reports of tongue ulceration

    Comment 17 January 2013 Pages: 5 - 5

12. 35 reports of disturbances of the sense of smell

    Comment 17 January 2013 Pages: 5 - 5

13. 362 reports of taste disturbances

    Comment 17 January 2013 Pages: 5 - 5

14. 45 reports of drug-associated tooth discolouration

    Comment 17 January 2013 Pages: 5 - 5

15. Nabumetone: worldwide safety experience

    Comment 17 January 2013 Pages: 5 - 5

16. Alcohol

    Case reports 17 January 2013 Pages: 6 - 6

17. Alfentanil

    Case report 17 January 2013 Pages: 6 - 6

18. Alteplase/streptokinase

    Incidence study 17 January 2013 Pages: 6 - 6

19. Amfebutamone

    Case report 17 January 2013 Pages: 6 - 6

20. Antineoplastics

    Case report 17 January 2013 Pages: 6 - 6

21. Antipsychotics

    Case reports 17 January 2013 Pages: 6 - 6

22. Antipsychotics

    Incidence study 17 January 2013 Pages: 6 - 6

23. Carbamazepine

    Case reports 17 January 2013 Pages: 7 - 7

24. Carboplatin/etoposide/ifosfamide

    Incidence study 17 January 2013 Pages: 7 - 7

25. Chloroquine

    Case report 17 January 2013 Pages: 7 - 7

26. Chlorpropamide

    Incidence study 17 January 2013 Pages: 7 - 7

27. Cimetidine interaction

    Case report 17 January 2013 Pages: 7 - 7

28. Clomifene/gonadorelin analogues

    Incidence study 17 January 2013 Pages: 7 - 7

29. Clomipramine

    Case reports 17 January 2013 Pages: 7 - 7

30. Colchicine

    Case report 17 January 2013 Pages: 8 - 8

31. Cyclophosphamide

    Incidence study 17 January 2013 Pages: 8 - 8

32. Cyclosporin

    Clinical study 17 January 2013 Pages: 8 - 8

33. Cytarabine

    Case report 17 January 2013 Pages: 8 - 8

34. Epoetin

    Case reports 17 January 2013 Pages: 8 - 8

35. Epoetin

    Correspondence 17 January 2013 Pages: 8 - 8

36. Estrogen/medroxyprogesterone

    Case report 17 January 2013 Pages: 8 - 8

37. Fluoxetine

    Case reports 17 January 2013 Pages: 9 - 9

38. Fluoxetine

    Case report 17 January 2013 Pages: 9 - 9

39. Fluvoxamine

    Case report 17 January 2013 Pages: 9 - 9

40. Glafenine

    Case report 17 January 2013 Pages: 9 - 9

41. Granulocyte colony-stimulating factor

    Case report 17 January 2013 Pages: 9 - 9

42. Heparin

    Case report 17 January 2013 Pages: 9 - 9

43. Heparin

    Incidence study 17 January 2013 Pages: 9 - 9

44. Ifosfamide

    Case reports 17 January 2013 Pages: 10 - 10

45. Immunoglobulin

    Incidence study 17 January 2013 Pages: 10 - 10

46. Immunoglobulins

    Case reports 17 January 2013 Pages: 10 - 10

47. Interferon alpha

    Case report 17 January 2013 Pages: 10 - 10

48. Interferon alpha

    Case report 17 January 2013 Pages: 10 - 10

49. Lithium

    Incidence study 17 January 2013 Pages: 10 - 10

50. Lithium

    Incidence study 17 January 2013 Pages: 11 - 11